These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26524855)

  • 1. [Biomarker Discovery of Colorectal Cancer Using Membrane Proteins Extracted from Cancer Tissues].
    Tomonaga T; Kume H
    Rinsho Byori; 2015 Mar; 63(3):322-7. PubMed ID: 26524855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysis.
    Kume H; Muraoka S; Kuga T; Adachi J; Narumi R; Watanabe S; Kuwano M; Kodera Y; Matsushita K; Fukuoka J; Masuda T; Ishihama Y; Matsubara H; Nomura F; Tomonaga T
    Mol Cell Proteomics; 2014 Jun; 13(6):1471-84. PubMed ID: 24687888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues.
    Takadate T; Onogawa T; Fukuda T; Motoi F; Suzuki T; Fujii K; Kihara M; Mikami S; Bando Y; Maeda S; Ishida K; Minowa T; Hanagata N; Ohtsuka H; Katayose Y; Egawa S; Nishimura T; Unno M
    Int J Cancer; 2013 Mar; 132(6):1368-82. PubMed ID: 22915188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression analysis of leucine-rich PPR-motif-containing protein (LRPPRC), a candidate colorectal cancer biomarker identified by shotgun proteomics using iTRAQ.
    Nishio T; Kurabe N; Goto-Inoue N; Nakamura T; Sugimura H; Setou M; Maekawa M
    Clin Chim Acta; 2017 Aug; 471():276-282. PubMed ID: 28622966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategy for SRM-based verification of biomarker candidates discovered by iTRAQ method in limited breast cancer tissue samples.
    Muraoka S; Kume H; Watanabe S; Adachi J; Kuwano M; Sato M; Kawasaki N; Kodera Y; Ishitobi M; Inaji H; Miyamoto Y; Kato K; Tomonaga T
    J Proteome Res; 2012 Aug; 11(8):4201-10. PubMed ID: 22716024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
    de Wit M; Jimenez CR; Carvalho B; Belien JA; Delis-van Diemen PM; Mongera S; Piersma SR; Vikas M; Navani S; Pontén F; Meijer GA; Fijneman RJ
    Gut; 2012 Jun; 61(6):855-64. PubMed ID: 21890811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
    Jimenez CR; Knol JC; Meijer GA; Fijneman RJ
    J Proteomics; 2010 Sep; 73(10):1873-95. PubMed ID: 20601272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer.
    Sugihara Y; Taniguchi H; Kushima R; Tsuda H; Kubota D; Ichikawa H; Sakamoto K; Nakamura Y; Tomonaga T; Fujita S; Kondo T
    J Proteomics; 2012 Sep; 75(17):5342-55. PubMed ID: 22735596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass Spectrometry-Based Analysis for the Discovery and Validation of Potential Colorectal Cancer Stool Biomarkers.
    Ang CS; Baker MS; Nice EC
    Methods Enzymol; 2017; 586():247-274. PubMed ID: 28137566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of potential colorectal cancer serum biomarkers through quantitative proteomics on the colonic tissue interstitial fluids from the AOM-DSS mouse model.
    Wang Y; Shan Q; Hou G; Zhang J; Bai J; Lv X; Xie Y; Zhu H; Su S; Li Y; Zi J; Lin L; Han W; Zhao X; Wang H; Xu N; Wu L; Lou X; Liu S
    J Proteomics; 2016 Jan; 132():31-40. PubMed ID: 26581642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic Profiling for Colorectal Cancer Biomarker Discovery.
    Álvarez-Chaver P; De Chiara L; Martínez-Zorzano VS
    Methods Mol Biol; 2018; 1765():241-269. PubMed ID: 29589313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
    Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
    BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
    Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
    J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.
    Mangé A; Dimitrakopoulos L; Soosaipillai A; Coopman P; Diamandis EP; Solassol J
    J Proteomics; 2016 Jun; 142():114-21. PubMed ID: 27168011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer.
    Bhardwaj M; Terzer T; Schrotz-King P; Brenner H
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cancer cell secretome: a good source for discovering biomarkers?
    Pavlou MP; Diamandis EP
    J Proteomics; 2010 Sep; 73(10):1896-906. PubMed ID: 20394844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large-scale and robust dynamic MRM study of colorectal cancer biomarkers.
    You J; Kao A; Dillon R; Croner LJ; Benz R; Blume JE; Wilcox B
    J Proteomics; 2018 Sep; 187():80-92. PubMed ID: 29953963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.